miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18319255 Hepatocellular carcinoma - 114550 Cancer liver miRNA overexpression - 1.23 - Patient study phenotype-control miRNA microarray
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.3 - Patient study phenotype-control quantitative PCR
18379589 Melanoma and neural system tumor syndrome - 155755 Cancer melanocyte miRNA overexpression - 1.4 - Patient study phenotype-control quantitative PCR
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, serous histotype - 0) Cancer ovary miRNA downregulation - 3.84615 - Patient study phenotype-control miRNA microarray
17363563 Colorectal cancer - 114500 Cancer Colo-201 cell miRNA downregulation - 1.6 - Cell culture study quantitative PCR
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - 3.84615 - Patient study phenotype-control miRNA microarray
18525125 Alzheimer disease, susceptibility to - 104300 Neurological cerebrospinal fluid miRNA overexpression - 1.95 - Patient study phenotype-phenotype quantitative PCR
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA overexpression - - - Cell culture study quantitative PCR
17222355 - - cell culture miRNA downregulation - 4.17 - Bioprocess study miRNA microarray
18442408 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary cancer cell miRNA overexpression - 4.37 - Patient study phenotype-phenotype quantitative PCR
18451214 Cervical cancer, somatic - 603956 Cancer cervical carcinoma cell miRNA overexpression - 9.037 - Patient study phenotype-control quantitative PCR
18478077 Leukemia, acute myeloid - 601626 Cancer blood miRNA overexpression - - - Patient study phenotype-control quantitative PCR
18308931 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 1.64 - Patient study phenotype-phenotype quantitative PCR
17712037 Supravalvar aortic stenosis - 185500 Cardiovascular myocardium miRNA downregulation - 1.49 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
19010987 Lung cancer - 211980 Cancer bronchial epithelium miRNA downregulation - 1.49 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 33.3333 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA downregulation - 25.0 - Cell culture study quantitative PCR
18766170 Lung cancer - 211980 Cancer serum miRNA downregulation - - - Patient study phenotype-control deep sequencing
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA downregulation - 4.0 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 4.0 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA downregulation - 3.57143 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 2.19 - Bioprocess study quantitative PCR
18647411 - - monocyte miRNA overexpression - 2.74 - Bioprocess study miRNA microarray
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR